Candel Therapeutics, Inc. (CADL) — Analyst estimates
Consensus analyst estimates for Candel Therapeutics, Inc. — earnings, revenue, and price targets.
| Fiscal Year | Revenue Forecast | EPS Forecast | analysts |
|---|---|---|---|
| 2026 | 0 | -0.27 | 1 |
| 2027 | 46.83M | -0.57 | 3 |
| 2028 | 169.57M | 0.72 | 5 |
| 2029 | 430.53M | 3.16 | 1 |
| 2030 | 823.44M | 6.62 | 1 |
Consensus analyst estimates by fiscal year.